Sign in

Amy C. Moore, PhD

@acmoorephd.bsky.social
1.6K followers 1.8K following 175 posts

Internationally-recognized KOL and patient advocate. Director, Patient Engagement & Advocacy at Summit Therapeutics. Views = my own

PostsRepliesMedia
Amy C. Moore, PhD @acmoorephd.bsky.social · 16/03/2025
Kiss them. They’re Irish. ☘️ 🌈
020
Reposted by Amy C. Moore, PhD
OncoDaily @oncodaily.bsky.social · 15/03/2025
Amy C. Moore is joining Summit Therapeutics as Director of Patient Engagement and Advocacy @acmoorephd.bsky.social oncodaily.com/blog/255749 #Cancer #Medicine #PatientAdvocacy #Health #HealthCare #Oncology #OncoDaily
oncodaily.com
Amy C. Moore is joining Summit Therapeutics as Director of Patient Engagement and Advocacy - OncoDaily
Amy C. Moore is joining Summit Therapeutics as Director of Patient Engagement and Advocacy / Amy C. Moore, cancer, ivonescimab, Lung cancer, OncoDaily,
092
Amy C. Moore, PhD @acmoorephd.bsky.social · 23/02/2025
Digging around in the basement and found this old award from AACR broken. But I glued it back together. Because science may be down right now, but it’s not out. We will put the pieces back together.
040
Reposted by Amy C. Moore, PhD
Eric Schmeltzer @ericschmeltzer.bsky.social · 04/02/2025
Here is the pre-RFK vaccination schedule for your kids. Please download it before he is confirmed and changes/deletes it. Give it to your pediatrician and say this is the schedule you want your kids on. Making this my pinned post.
10358363704
Amy C. Moore, PhD @acmoorephd.bsky.social · 02/02/2025
I am proud to have worked with LUNGevity’s partners to develop these #lungcancer resources for members of the AANHPI community lungevity.org/health-equity #LCSM
091
Reposted by Amy C. Moore, PhD
LUNGevity Foundation @lungevity.bsky.social · 01/02/2025
As February begins, we embrace a month dedicated to recognizing the extraordinary achievements of Black individuals who have shaped our world. Their stories inspire us to rise, challenge the status quo, and create a future filled with hope and progress.
051
Reposted by Amy C. Moore, PhD
Christina Areizaga Barbieri, Ph.D. @cabarbieri.bsky.social · 27/01/2025
I’m an NSF panel reviewer that was scheduled to meet today. Just got notice that all NSF panels were canceled today. I reviewed some innovative proposals in support of students. Devastating if these scholars don’t get to do this work. For the love of science & students I hope this is just a delay.💔
682274719
Amy C. Moore, PhD @acmoorephd.bsky.social · 27/01/2025
Having landed my first job outside my postdoc through a cold email, I know the power of that communication and how it can open doors www.nature.com/articles/d41...
nature.com
Four tips for writing the perfect ‘cold e-mail’ in job applications
These strategies can transform your unsolicited applications from forgettable to fabulous.
020
Amy C. Moore, PhD @acmoorephd.bsky.social · 27/01/2025
As a scientist and an advocate, I am grateful for LUNGevity's commitment to continue to work on behalf of ALL people at risk for and impacted by #lungcancer as well as the researchers working to find new treatments. #LCSM
260
Amy C. Moore, PhD @acmoorephd.bsky.social · 26/01/2025
This will not get better www.nature.com/articles/d41...
nature.com
More than 40% of postdocs leave academia, study reveals
Publishing highly cited papers helps postdoctoral researchers to land a faculty job.
011
Amy C. Moore, PhD @acmoorephd.bsky.social · 25/01/2025
www.statnews.com/2025/01/25/t...
statnews.com
Are you affected by the Trump administration’s pause on health communications, science meetings, and reviews?
Have you been affected by the Trump administration’s pause on communications, science meetings, and reviews? @statnews would like to hear from you.
140
Amy C. Moore, PhD @acmoorephd.bsky.social · 25/01/2025
The good news is my ping pong game has really improved this week. Burning off some steam!
media.tenor.com
a cat is sitting on a ping pong table looking at a blue balloon .
ALT: a cat is sitting on a ping pong table looking at a blue balloon .
010
Reposted by Amy C. Moore, PhD
Oncogene Cancer Research @oncogenecancer.bsky.social · 25/01/2025
As a cancer patient community, we are lost for words. Science and research is what keeps us all going. As Dr @choo.bsky.social said, “There are real people, real lives waiting on the science.” nature.com/articles/d4158… #LCSM
nature.com
03111
Amy C. Moore, PhD @acmoorephd.bsky.social · 25/01/2025
A good distraction from a cat-astrophic week for science
1173
Amy C. Moore, PhD @acmoorephd.bsky.social · 24/01/2025
Efforts to support clinical trial diversity now at risk www.statnews.com/2025/01/23/f...
statnews.com
FDA purges material on clinical trial diversity from its site, showing stakes of Trump DEI ban
Following the Trump administration's DEI ban, the FDA's move to scrub webpages has ensnared many pages focused on ensuring diversity in drug trials.
195
Amy C. Moore, PhD @acmoorephd.bsky.social · 23/01/2025
One of my frustrations with our work to understand the causes of #cancer #cachexia as part of Cancer Grand Challenges Team #CANCAN is the limitation of animal models that don't reflect the realities of the patient population. This development helps. #LCSM #lungcancer www.biorxiv.org/content/10.1...
biorxiv.org
Concurrent PIK3CA mutant drives cachexia through inflammatory signaling in EGFR mutant lung cancer
PIK3CA mutation is frequently concurrent with known oncogenic drivers such as EGFR mutation in lung cancer, raising an interesting question about its real function. Cachexia is a systemic disease invo...
0114
Amy C. Moore, PhD @acmoorephd.bsky.social · 23/01/2025
On this day 13 years ago, I was speaking at the Georgia Capitol about the importance of #cancer #research. Despite what happened yesterday, we continue our work on behalf of those around the world at risk for, living with or impacted by #cancer.
0131
Reposted by Amy C. Moore, PhD
@doublewhammied @doublewhammied.bsky.social · 23/01/2025
"Any prolonged pause of the #NIH’s study sections could result in funding delays for scientific labs awaiting approval of their work." #CanSky #MedSky #IDSky www.statnews.com/2025/01/22/t...
statnews.com
Trump administration’s abrupt cancellation of scientific meetings prompts confusion, concern
A flurry of scientific gatherings and panels across federal science agencies were canceled on Wednesday, at a time of heightened sensitivity about how the
4178
Amy C. Moore, PhD @acmoorephd.bsky.social · 22/01/2025
www.reuters.com/world/us/tru...
reuters.com
Trump officials ask US health agencies to pause external communications, Washington Post reports
The administration of U.S. President Donald Trump has instructed federal health agencies to pause all external communications, such as health advisories, weekly scientific reports, updates to websites and social media posts, the Washington Post reported on Tuesday, citing a dozen current and former officials and sources.
120
Reposted by Amy C. Moore, PhD
OncLive @onclive.bsky.social · 21/01/2025
First-Line Amivantamab Plus Lazertinib Wins EU Approval for EGFR+ Advanced NSCLC #lcsm #oncology www.onclive.com/view/first-l...
onclive.com
First-Line Amivantamab Plus Lazertinib Wins EU Approval for EGFR+ Advanced NSCLC
The European Commission approved first-line amivantamab plus lazertinib for EGFR-mutated advanced non–small cell lung cancer.
073
Amy C. Moore, PhD @acmoorephd.bsky.social · 20/01/2025
My cat may be slightly spoiled
140
Reposted by Amy C. Moore, PhD
Annie Wong 黃毅敏 @anmwongnz.bsky.social · 19/01/2025
9.5% MET and 7.9% EGFR detected in pts w lung SqCC with no smoking history. Important to improve testing in this group. We are finding more of this with reflex testing in early stage disease. #lcsm
194
Amy C. Moore, PhD @acmoorephd.bsky.social · 19/01/2025
We still have a long way to go to ensure that ALL patients benefit from recent scientific advances in #lungcancer. This study found that overall survival increased by 71% in patients with private insurance compared to only 24% in the uninsured in the US. #LCSM www.jtocrr.org/article/S266...
jtocrr.org
Recent Survival Gains in Stage IV Non-Small Cell Lung Cancer by Sociodemographic Strata
The management of stage IV non-small cell lung cancer (NSCLC) has been transformed by recent innovations. However, access to medical innovations can be variable across sociodemographic groups in the U...
1166
Amy C. Moore, PhD @acmoorephd.bsky.social · 19/01/2025
Biomarker testing can help identify actionable mutations in patients with SqNSCLC, especially in those without a history of smoking. Testing is not performed consistently in this setting. #LCSM #lungcancer www.sciencedirect.com/science/arti...
sciencedirect.com
Comprehensive molecular profiling of squamous non-small cell lung cancer reveals high incidence of actionable genomic alterations among patients with no history of smoking
Next-generation sequencing (NGS) to detect actionable genomic driver alterations (AGAs) is critical to appropriate management of non-small cell lung c…
0102
Reposted by Amy C. Moore, PhD
Laura Alder, MD @lauraaldermd.bsky.social · 07/01/2025
Excellent review of lung neuroendocrine neoplasms by Dr Sen, @naglaakarimmd.bsky.social and team! Terrific discussion of molecular landscape, existing therapeutic challenges, and diagnosis & management strategies. #LCSM #LungNETs #SCLC @thelancet.bsky.social www.thelancet.com/journals/lan...
083
Reposted by Amy C. Moore, PhD
Jill Feldman @jillfeldman4.bsky.social · 14/01/2025
THIS! Easy-to-use, available regimen significantly ⬇️ frequency & severity of Grade 2+ AEs SOC for patients on first-line Ami/Lazer. Like “Stay ahead of the pain,” “Stay ahead of the side effects” boosts QOL & ⬇️ dose interrupt/discontine—a win for everyone. 👏 #LCSM #SuppOnc bit.ly/4jiKwUz
bit.ly
COCOON study meets primary endpoint demonstrating statistically significant and clinically meaningful reduction in dermatologic reactions with easy-to-use prophylactic regimen for patients with EGFR-m...
0122
Reposted by Amy C. Moore, PhD
Jill Feldman @jillfeldman4.bsky.social · 16/01/2025
Words Matter isn't just a catchphrase. It is a simple yet profound truth when talking about #lungcancer Thank you, Drs Jamie Ostroff & Smita Banerjee, for your efforts to develop a training that offers strategies for empathic communication to ⬇️ stigma bit.ly/4gWH1Si #LCSM #EndStigmaNow
bit.ly
Helping Health Professionals Reduce Lung Cancer Stigma
Researchers have developed a training program to help health providers reduce lung cancer stigma and have launched a clinical trial to test the training.
082
Amy C. Moore, PhD @acmoorephd.bsky.social · 19/01/2025
LUNGevity's RFA Day was Jan 13. Our newest mechanism is my baby. We are excited to offer bridge funding to mid-career investigators working in the #lungcancer space. We support workforce development AND retention to ensure a continuous pipeline of leaders to transform the field and improve outcomes.
061
Amy C. Moore, PhD @acmoorephd.bsky.social · 19/01/2025
Very interesting given my work in the #lungcancer and #cancer #cachexia space. Are patients with RET+ NSCLC on TKIs protected against cachexia and could RET drugs protect patients with other oncogene driven NSCLC (ex EGFR) where weight loss often occurs? #LCSM www.sciencedirect.com/science/arti...
sciencedirect.com
Selpercatinib mitigates cancer cachexia independent of anti-tumor activity in the HT1080 tumor model
Anorexia is a major cause of cancer cachexia and is induced by growth differentiation factor-15 (GDF15), which activates the rearranged during transfe…
181
Amy C. Moore, PhD @acmoorephd.bsky.social · 12/01/2025
I am holding space…for my cat 😂❤️
030
Reposted by Amy C. Moore, PhD
OncoDaily @oncodaily.bsky.social · 06/01/2025
PD-1/VEGF combos are a strategy to watch in lung cancer - Amy Moore @acmoorephd.bsky.social oncodaily.com/insight/amy-... #Cancer #ImmuneCheckpointInhibitors #LungCancer #Health #NSCLC #OncoDaily #Oncology #Medicine
oncodaily.com
Amy Moore: PD-1/VEGF combos are a strategy to watch in lung cancer - OncoDaily
Amy Moore: PD-1/VEGF combos are a strategy to watch in lung cancer / Amy Moore, cancer, Immune Checkpoint Inhibitors, Keiju Aokage, Lung cancer, Masahiro
0102
Amy C. Moore, PhD @acmoorephd.bsky.social · 06/01/2025
120
Amy C. Moore, PhD @acmoorephd.bsky.social · 06/01/2025
Individual in Louisiana has died from #H5N1 #birdflu, marking first US death from the virus.
1156
Amy C. Moore, PhD @acmoorephd.bsky.social · 05/01/2025
0 ⭐️, does not recommend 😂
020
Amy C. Moore, PhD @acmoorephd.bsky.social · 05/01/2025
We were the only fools in our neighborhood sledding but we had fun! Lots of powder on top of the ice!
030
Reposted by Amy C. Moore, PhD
The New York Times @nytimes.com · 04/01/2025
The clawed footprints of a 30-foot-tall predator and the sunken tracks of other dinosaurs were discovered in England, in what paleontologists are calling one of the most significant finds in Britain in nearly three decades.
nytimes.com
Dinosaur Footprints Found in England by Quarry Workers
The prints were made by both long-necked sauropods and a predator, megalosaurus, and were found in one of the largest discoveries in decades.
201027142
Amy C. Moore, PhD @acmoorephd.bsky.social · 03/01/2025
@jfreemandaily.bsky.social
010
Amy C. Moore, PhD @acmoorephd.bsky.social · 03/01/2025
www.cnn.com/2025/01/03/h...
cnn.com
US Surgeon General sounds alarm about link between alcohol and cancer | CNN
The advisory “highlights alcohol use as a leading preventable cause of cancer in the United States, contributing to nearly 100,000 cancer cases and about 20,000 cancer deaths each year.”
100
Amy C. Moore, PhD @acmoorephd.bsky.social · 02/01/2025
That time in Jan 2020 when HomeGoods tried to warn me
020
Reposted by Amy C. Moore, PhD
Tatiana Prowell, MD @tmprowell.bsky.social · 01/01/2025
🧵 #MedSky #IDSky #PublicHealth IMPORTANT The case of this 🇨🇦 adolescent with #H5N1 #BirdFlu is terrifying. Her only medical history was mild asthma, & symptoms started w/ fever and conjunctivitis. On d5 from symptom onset, she was admitted in respiratory failure, kidney failure, in shock … /1
media.tenor.com
the word warning is glowing brightly in red on a black background
ALT: the word warning is glowing brightly in red on a black background
37425
Amy C. Moore, PhD @acmoorephd.bsky.social · 01/01/2025
One thing I learned from patients with #cancer is that words matter. "Prevention" is triggering for many - suggesting that perhaps they didn't do the "right" things. For individuals (not populations), "risk reduction" is preferred. A lesson I carry today from those living with this disease.
2102
Amy C. Moore, PhD @acmoorephd.bsky.social · 01/01/2025
Be careful who you kiss tonight! Flu and other respiratory viruses are crashing the party
020
Amy C. Moore, PhD @acmoorephd.bsky.social · 01/01/2025
My NYE date is dressed in his finest tuxedo. And he’s sneaking kisses early. 😂
090
Amy C. Moore, PhD @acmoorephd.bsky.social · 31/12/2024
Reflecting on 2024 and how lucky and grateful I am to be able to combine my love of science with my heart for people in service of those living with and impacted by #cancer www.linkedin.com/posts/amy-c-...
linkedin.com
Amy C. Moore, PhD on LinkedIn: #lungcancer #cancer
My own 2024 rewind in pics. So grateful to be able to combine my love of science with my heart for people, working across the #lungcancer community and beyond.…
0143
Amy C. Moore, PhD @acmoorephd.bsky.social · 31/12/2024
This presentation I did with @jfreemandaily.bsky.social and the IASLC STARS program is now several years old but is still a good primer for patients and caregivers to understand the various types of data plots used in #cancer #clinicaltrials youtu.be/8CAv4Wnc2I0?...
youtu.be
What do all those lines and colors mean? Interpreting cancer data plots.
YouTube video by IASLC
150
Amy C. Moore, PhD @acmoorephd.bsky.social · 31/12/2024
Dr. Solange Peters is a hero to so many of us in the #lungcancer and #oncology community. We were incredibly honored to have her as the keynote speaker for LUNGevity's #ILCSC24. You have until midnight to watch her inspiring presentation - don't miss it! reg.eventmobi.com/ilcsc24
081
Reposted by Amy C. Moore, PhD
OncoDaily @oncodaily.bsky.social · 30/12/2024
FDA Approved Subcutaneous Nivolumab in Advanced or Metastatic Solid Tumors @fda.gov oncodaily.com/insight/fda-... #AdvancedTumor #Cancer #CHECKMATE-67Ttrial #FDA #MetastaticSolidTumors #Nivolumab #OncoDaily #Health #Oncology #Medicine
oncodaily.com
FDA Approved Subcutaneous Nivolumab in Advanced or Metastatic Solid Tumors - OncoDaily
FDA Approved Subcutaneous Nivolumab in Advanced or Metastatic Solid Tumors / advanced tumor, Bogdan Zurawski, cancer, CHECKMATE-67T trial, Dhanrajsinh Rathod,
2153
Amy C. Moore, PhD @acmoorephd.bsky.social · 29/12/2024
What a legacy President Carter leaves of true humanitarianism and Christianity www.ajc.com/news/former-...
ajc.com
Former U.S. President Jimmy Carter, 100, dies
Former U.S. President Jimmy Carter has died at home in Georgia.
040
Amy C. Moore, PhD @acmoorephd.bsky.social · 29/12/2024
#LCSM
001
Reposted by Amy C. Moore, PhD
Helen Branswell 🇨🇦 @helenbranswell.bsky.social · 29/12/2024
1. A belated bit of #flu news: #CDC has been informed of 5 more pediatric flu deaths this season, all of which occurred this month. They bring the total to date this season to 9. Kids 6 months and older can be vaccinated against flu. www.cdc.gov/fluview/surv...
623688